CSIMarket Company Name, Ticker, Customers, else..
 
Dermata Therapeutics Inc   (NASDAQ: DRMA)
 

Dermata Therapeutics Inc's Suppliers Performance

DRMA's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
DRMA Costs vs Sales of Suppliers Growth

• More on DRMA Suppliers






Dermata Therapeutics Inc's Comment on Supply Chain


The company sources Spongilla raw materials primarily from Reka-Farm LLC, which complies with their quality standards and current Good Manufacturing Practices (cGMP). Although other global suppliers have been evaluated, none met the company's quality requirements. An alternative method considered is lab-based aquaculture of Spongilla, but this approach would increase costs and impact availability. The company implements strict quality control processes and collaborates with manufacturers compliant with current Good Laboratory Practices (cGLP) and cGMP. Supplier selection is based on organizational capabilities, regulatory compliance, personnel qualifications, and equipment. Testing and analytical methods are developed and validated at various production stages to ensure product quality.

Dermata Therapeutics Inc's Comment on Supply Chain


The company sources Spongilla raw materials primarily from Reka-Farm LLC, which complies with their quality standards and current Good Manufacturing Practices (cGMP). Although other global suppliers have been evaluated, none met the company's quality requirements. An alternative method considered is lab-based aquaculture of Spongilla, but this approach would increase costs and impact availability. The company implements strict quality control processes and collaborates with manufacturers compliant with current Good Laboratory Practices (cGLP) and cGMP. Supplier selection is based on organizational capabilities, regulatory compliance, personnel qualifications, and equipment. Testing and analytical methods are developed and validated at various production stages to ensure product quality.







DRMA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Dermata Therapeutics Inc 4.71 0.00 -8.37 9
SUBTOTAL 0.00 0.00 0.00 -


Sources: Dermata Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Dermata Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.